US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 29, 2021 (5 years ago)

Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.

What was recalled

Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01

Recalling firm
Eli Lilly & Company
NDC code
0002-7597-01
Origin
IN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0720-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Pine recalls

See all